Tirzepatide - 10mg Vial

10mg vial of Tirzepatide: [Powder]
For research purposes ONLY

Tirzepatide is a synthetic peptide, specifically a dual agonist for both GIP and GLP-1 receptors, used in the treatment of type 2 diabetes and weight management. It consists of a 39 amino acid peptide chain, based on the GIP sequence, with modifications that enhance its stability and half-life. A C20 fatty diacid is attached to a lysine residue via a linker, which includes a γ-glutamic acid and two 8-amino-3,6-dioxaoctanoic acids. This fatty acid modification is key to its long half-life and ability to bind to albumin, allowing for once-weekly dosing.

Sequence: Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-C20-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Molecular Formula: C225H348N48O68
Molecular Weight: 4813g/mol
CAS Number: 2023788-19-2
PubChem CID: 163285897
Synonyms: Zepbound; Mounjaro

Source: PubChem